Literature DB >> 79759

Plasma-triglycerides in regulation of H.D.L.-cholesterol levels.

E J Schaefer, R I Levy, D W Anderson, R N Danner, H B Brewer, W C Blackwelder.   

Abstract

Plasma-high-density-lipoprotein (H.D.L.) cholesterol concentrations are lower in patients with coronary-artery disease than in control subjects. In an investigation of the relationship of H.D.L. cholesterol to other lipid and lipoprotein parameters in normal and hyperlipoproteinaemic subjects inverse correlations were found between H.D.L. cholesterol and very-low-density-lipoprotein (V.L.D.L.) cholesterol, and between H.D.L. cholesterol and plasma-triglyceride levels. Mean H.D.L.-cholesterol concentrations in normal subjects were 50 mg/dl, and in hyperlipoproteinaemic patients they were: type I, 17 mg/dl; type II, 44 mg/dl; type III, 38 mg/dl; type IV, 37 mg/dl; and type V, 27 mg/dl. H.D.L.-cholesterol levels were lowest in patients with fasting chylomicronaemia and were diminished in hypertriglyceridaemic subjects, suggesting a relationship between the metabolism of triglyceride-rich lipoproteins and H.D.L.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79759     DOI: 10.1016/s0140-6736(78)91863-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  The composition and metabolism of high density lipoprotein subfractions.

Authors:  E J Schaefer; D M Foster; L L Jenkins; F T Lindgren; M Berman; R I Levy; H B Brewer
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

2.  High-density lipoprotein in chronic renal failure and after renal transplantation.

Authors:  E Savdie; J C Gibson; J H Stewart; L A Simons
Journal:  Br Med J       Date:  1979-04-07

3.  Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.

Authors:  Margaret R Diffenderfer; Margaret E Brousseau; John S Millar; P Hugh R Barrett; Chorthip Nartsupha; Peter M Schaefer; Megan L Wolfe; Gregory G Dolnikowski; Daniel J Rader; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2012-04-02       Impact factor: 5.922

4.  Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects.

Authors:  Michael Miller; Patricia Langenberg; Stephen Havas
Journal:  Int J Cardiol       Date:  2006-10-18       Impact factor: 4.164

5.  Relationships between metabolic and hemostatic variables in uncomplicated diabetes.

Authors:  C Vergani; G Bettale; D Mari; P M Mannucci
Journal:  Acta Diabetol Lat       Date:  1981 Jul-Sep

6.  Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.

Authors:  M Stalder; D Pometta; A Suenram
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

Review 7.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

Review 8.  Diagnosis and treatment of high density lipoprotein deficiency.

Authors:  Ernst J Schaefer; Pimjai Anthanont; Margaret R Diffenderfer; Eliana Polisecki; Bela F Asztalos
Journal:  Prog Cardiovasc Dis       Date:  2016-08-24       Impact factor: 8.194

9.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

Authors:  I Hardardóttir; A H Moser; J Fuller; C Fielding; K Feingold; C Grünfeld
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.

Authors:  G Ghiselli; E J Schaefer; L A Zech; R E Gregg; H B Brewer
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.